Home
 /
Papers
 /
Neuroscience
 /
Dose-dependent NFI regulation of progenitor lifespan and output underlying human neocortical malformation
Preprint
Open access
V1
Top 1% · Validated by QED

Dose-dependent NFI regulation of progenitor lifespan and output underlying human neocortical malformation

Qiangqiang Zhang, Guohua Yuan, Elena Albizzati +21 more
December 2025
 ·
bioRxiv
 ·
DOI 
10.64898/2025.12.27.696675
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Neuroscience this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By establishing NFIs as dose-dependent global temporal clocks governing the entire radial glial progenitor lifespan, this work overturns their prior identity as late gliogenic factors and provides a unified mechanistic explanation for human cortical malformations.

QED claims analysis

Summary

Nuclear Factor I (NFI) transcription factors function as evolutionarily conserved global temporal regulators that control radial glial progenitor lineage progression rate and lifespan in a dose-dependent manner through progressive expression and autoregulation, whereby they sequentially regulate distinct temporal-specific transcription factor networks governing the transitions from proliferation to neurogenesis to gliogenesis, with NFI misexpression causing bidirectional alterations in progenitor temporal identity and progeny output that directly correspond to human brain malformation phenotypes including macrocephaly and microcephaly.

See full analysis
Main Claim 1 –

NFI Dosage Bidirectionally Controls Human RGP Lineage Progression

Main Claim 2 –

RGP-Specific NFIA/NFIX Loss Causes Cortical Overgrowth and Folding

Main Claim 3 –

NFIA/NFIX Loss Prolongs RGP Lineage Progression and Lifespan

Supporting evidence

  • NFIA/NFIX Overexpression Accelerates RGP Progression with Stage-Specific Output
Main Claim 4 –

NFIs Drive RGP Progression via Temporal-Specific Gene Networks

Supporting evidence

  • Positive NFI Autoregulation Drives Progressive Expression During RGP Development
  • NFI Dosage Controls RGP Temporal Identity with Species Differences

Abstract

Nuclear Factor I (NFI) misexpressions in humans are associated with severe brain malformations, yet the underlying mechanisms remain poorly understood. Here we show that NFIs regulate the broad lineage progression and lifespan of radial glial progenitors (RGPs), and consequently neocortical development in a dose-dependent manner. Human cerebral organoids carrying patient-mimicking NFI mutations exhibit expression level-dependent bidirectional impairments in RGP temporal development, coinciding with patient phenotypes. In mouse models, selective removal of NFIs leads to a dramatic protraction of RGP lineage progression and lifespan, excessive progeny output, and neocortical overgrowth and abnormal folding, whereas overexpression of NFIs accelerates RGP lineage progression, resulting in developmental stage-dependent precocious productions of diverse neural progenies. Moreover, NFIs exhibit a positive auto-regulation and progressive increase in expression, and regulate distinct temporal-specific targets underlying RGP lineage progression. These results suggest that NFIs act as evolutionarily conserved key global temporal regulators of RGP lineage progression and neocortical development.

HIGHLIGHTS

NFIs affect human RGP temporal development coinciding with patient phenotypes.

NFI removal protracts RGP lineage progression and lifespan with excessive progeny output.

NFI overexpression accelerates RGP lineage progression with precocious progeny output.

NFIs regulate distinct temporal-specific targets underlying RGP lineage progression.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?